Emkay Global Financial Services Limited has formally notified stock exchanges about its upcoming board meeting scheduled for May 15, 2026. The announcement, made on April 30, 2026, fulfills regulatory requirements under Regulations 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting will address two primary matters of significant importance to shareholders and stakeholders:

The comprehensive review will encompass both quarterly and annual performance metrics, providing stakeholders with complete financial transparency for the concluded fiscal year.

Trading Window Restrictions

In compliance with the company's Code of Conduct for Prevention of Insider Trading, Emkay Global Financial Services has implemented trading window restrictions. The trading window for dealing in company securities remains closed and will continue until May 17, 2026. This closure was previously communicated to exchanges on March 30, 2026, ensuring adherence to insider trading prevention protocols.

Regulatory Compliance

The company has fulfilled all mandatory disclosure requirements by notifying both major stock exchanges:

• NSE: Equity Scrip Code EMKAY
• BSE: Equity Scrip Code 532737, Debt Scrip Codes 976528, 977388

Additionally, the information has been made available on the company's investor relations website at emkayglobal.com, ensuring transparent communication with all stakeholders as required under Regulation 46(2) of SEBI Listing Regulations.

The formal communication was signed by B. M. Raul, Company Secretary & Compliance Officer, maintaining proper corporate governance standards throughout the disclosure process.

Emkay Global Financial Services Limited has completed the allotment of 1,47,668 equity shares under its Employee Stock Option Plans (ESOP) following approval from the Nomination, Remuneration and Compensation (NRC) Committee through a circular resolution passed on April 10, 2026.

ESOP Allotment Details

The NRC Committee approved two separate allotments under the company's ESOP schemes. Under the ESOP-2007 scheme, 35,250 equity shares of Rs. 10 each were allotted to an eligible employee of the foreign subsidiary company upon exercise of vested stock options. Additionally, under the ESOP-2018 scheme, 1,12,418 equity shares of Rs. 10 each were allotted to eligible employees of the company upon exercise of their vested stock options.

Exercise Price Structure

The shares were allotted at varying exercise prices across different tranches. Under ESOP-2007, all 35,250 equity shares were exercised at Rs. 78.95 per share with a premium of Rs. 68.95 each. The ESOP-2018 scheme had multiple exercise price points reflecting different grant periods and market conditions at the time of grant.

Impact on Share Capital

Following the allotment of equity shares under both ESOP schemes, the company's issued, subscribed and paid-up equity share capital has increased significantly. The total number of equity shares outstanding increased from 2,61,89,063 to 2,63,36,731 equity shares of Rs. 10 each. This translates to a total issued share capital of Rs. 26,33,67,310 after the current allotment.

Regulatory Compliance

The allotment was conducted in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has informed both BSE Limited and National Stock Exchange of India Limited about the allotment, providing comprehensive details as required under the regulatory framework. The newly allotted equity shares will rank pari-passu with existing equity shares, including entitlement to dividend payments, and carry no lock-in restrictions post-allotment.